Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|August 6, 2011
Glucocorticoid receptor and breast cancerMyriam Vilasco, Laudine Communal, Najat Mourra, et al.
Scientific Reports|October 18, 2017
Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersMarilyne Labrie, Lorenna Oliveira Fernandes De Araujo, Laudine Communal, et al.
International Journal of Molecular Sciences|June 2, 2021
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma PrognosisLaudine Communal, Noemi Roy, Maxime Cahuzac, et al.
Scientific Reports|September 28, 2019
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian CancerMeshach Asare-Werehene, Laudine Communal, Euridice Carmona, et al.
Breast Cancer Research and Treatment|March 10, 2016
Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissueMyriam Vilasco, Laudine Communal, Justine Hugon-Rodin, et al.
Breast Cancer Research and Treatment|October 30, 2013
Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissueMyriam Vilasco, Laudine Communal, Justine Hugon-Rodin, et al.
RNA (New York, N.Y.)|January 14, 2026
Localized regulation of cell junction mRNAs is required for epithelial cell integrityAshley Chin, Jonathan Bergeman, Laudine Communal, et al.
Human Reproduction (Oxford, England)|June 29, 2012
Ulipristal acetate does not impact human normal breast tissueLaudine Communal, Myriam Vilasco, Justine Hugon-Rodin, et al.
Frontiers in Immunology|July 29, 2025
Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mightyMeshach Asare-Werehene, Arvin Zaker, Shivanshi Tripathi, et al.
Pageof 3